561 related articles for article (PubMed ID: 33967780)
21. Revisiting the Paraquat-Induced Sporadic Parkinson's Disease-Like Model.
Bastías-Candia S; Zolezzi JM; Inestrosa NC
Mol Neurobiol; 2019 Feb; 56(2):1044-1055. PubMed ID: 29862459
[TBL] [Abstract][Full Text] [Related]
22. Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies.
Zhang XW; Chen JY; Ouyang D; Lu JH
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941000
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse.
Srivastava G; Dixit A; Yadav S; Patel DK; Prakash O; Singh MP
Free Radic Biol Med; 2012 Apr; 52(8):1294-306. PubMed ID: 22334051
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
Guo CH; Cao T; Zheng LT; Waddington JL; Zhen XC
Acta Pharmacol Sin; 2020 Apr; 41(4):499-507. PubMed ID: 32112040
[TBL] [Abstract][Full Text] [Related]
25. Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.
Mack JM; Schamne MG; Sampaio TB; Pértile RA; Fernandes PA; Markus RP; Prediger RD
Oxid Med Cell Longev; 2016; 2016():3472032. PubMed ID: 27829983
[TBL] [Abstract][Full Text] [Related]
26. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity.
Srivastav S; Neupane S; Bhurtel S; Katila N; Maharjan S; Choi H; Hong JT; Choi DY
J Nutr Biochem; 2019 Jul; 69():73-86. PubMed ID: 31063918
[TBL] [Abstract][Full Text] [Related]
27. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
[TBL] [Abstract][Full Text] [Related]
28. Effects of quercetin in preclinical models of Parkinson's disease: A systematic review.
de Oliveira Vian C; Marinho MAG; da Silva Marques M; Hort MA; Cordeiro MF; Horn AP
Basic Clin Pharmacol Toxicol; 2024 Jul; 135(1):3-22. PubMed ID: 38682342
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease.
Giuliano C; Siani F; Mus L; Ghezzi C; Cerri S; Pacchetti B; Bigogno C; Blandini F
Nutrition; 2020 Jan; 69():110494. PubMed ID: 31586482
[TBL] [Abstract][Full Text] [Related]
30. Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model.
Xue B; Xiao W; Tian H
Biochem Biophys Res Commun; 2020 Jan; 521(1):245-251. PubMed ID: 31653343
[TBL] [Abstract][Full Text] [Related]
31. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease.
Mei M; Zhou Y; Liu M; Zhao F; Wang C; Ding J; Lu M; Hu G
Neuropharmacology; 2019 Dec; 160():107758. PubMed ID: 31494143
[TBL] [Abstract][Full Text] [Related]
32. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
Tapias V; Cannon JR; Greenamyre JT
J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
[TBL] [Abstract][Full Text] [Related]
33. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.
Lee KM; Lee Y; Chun HJ; Kim AH; Kim JY; Lee JY; Ishigami A; Lee J
J Neurosci Res; 2016 Oct; 94(10):865-78. PubMed ID: 27265894
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
[TBL] [Abstract][Full Text] [Related]
37. Sex-specific neuroprotection by inhibition of the Y-chromosome gene,
Lee J; Pinares-Garcia P; Loke H; Ham S; Vilain E; Harley VR
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16577-16582. PubMed ID: 31371505
[TBL] [Abstract][Full Text] [Related]
38. Preclinical Evidence and Possible Mechanisms of Baicalein for Rats and Mice With Parkinson's Disease: A Systematic Review and Meta-Analysis.
Wang Y; Wei N; Li X
Front Aging Neurosci; 2020; 12():277. PubMed ID: 33101006
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging.
Lu KT; Ko MC; Chen BY; Huang JC; Hsieh CW; Lee MC; Chiou RY; Wung BS; Peng CH; Yang YL
J Agric Food Chem; 2008 Aug; 56(16):6910-3. PubMed ID: 18616261
[TBL] [Abstract][Full Text] [Related]
40. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
